» Articles » PMID: 20686026

Simian Virus 40 Activates ATR-Delta P53 Signaling to Override Cell Cycle and DNA Replication Control

Overview
Journal J Virol
Date 2010 Aug 6
PMID 20686026
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

During infection, simian virus 40 (SV40) attempts to take hold of the cell, while the host responds with various defense systems, including the ataxia-telangiectasia mutated/ATM-Rad3 related (ATM/ATR)-mediated DNA damage response pathways. Here we show that upon viral infection, ATR directly activates the p53 isoform Δp53, leading to upregulation of the Cdk inhibitor p21 and downregulation of cyclin A-Cdk2/1 (AK) activity, which force the host to stay in the replicative S phase. Moreover, downregulation of AK activity is a prerequisite for the generation of hypophosphorylated, origin-competent DNA polymerase α-primase (hypo-Polα), which is, unlike AK-phosphorylated Polα (P-Polα), recruited by SV40 large T antigen (T-Ag) to initiate viral DNA replication. Prevention of the downregulation of AK activity by inactivation of ATR-Δp53-p21 signaling significantly reduced the T-Ag-interacting hypo-Polα population and, accordingly, SV40 replication efficiency. Moreover, the ATR-Δp53 pathway facilitates the proteasomal degradation of the 180-kDa catalytic subunit of the non-T-Ag-interacting P-Polα, giving rise to T-Ag-interacting hypo-Polα. Thus, the purpose of activating the ATR-Δp53-p21-mediated intra-S checkpoint is to maintain the host in S phase, an optimal environment for SV40 replication, and to modulate the host DNA replicase, which is indispensable for viral amplification.

Citing Articles

Quercetin inhibition of porcine intestinal alpha coronavirus in vitro and in vivo.

Feng Y, Yi H, Zheng X, Liu X, Gong T, Wu D BMC Vet Res. 2024; 20(1):134.

PMID: 38570774 PMC: 10988794. DOI: 10.1186/s12917-024-03984-2.


ORFV infection enhances CXCL16 secretion and causes oncolysis of lung cancer cells through immunogenic apoptosis.

Wang R, Mo J, Luo X, Zhang G, Liu F, Luo S Front Cell Infect Microbiol. 2022; 12:910466.

PMID: 35959371 PMC: 9358046. DOI: 10.3389/fcimb.2022.910466.


ATR-mediated proteome remodeling is a major determinant of homologous recombination capacity in cancer cells.

Kim D, Liu Y, Oberly S, Freire R, Smolka M Nucleic Acids Res. 2018; 46(16):8311-8325.

PMID: 30010936 PMC: 6144784. DOI: 10.1093/nar/gky625.


RGNNV-induced cell cycle arrest at G1/S phase enhanced viral replication via p53-dependent pathway in GS cells.

Mai W, Liu H, Chen H, Zhou Y, Chen Y Virus Res. 2018; 256:142-152.

PMID: 29940189 PMC: 7114848. DOI: 10.1016/j.virusres.2018.06.011.


Newcastle disease virus induces G/G cell cycle arrest in asynchronously growing cells.

Wang Y, Wang R, Li Y, Sun Y, Song C, Zhan Y Virology. 2018; 520:67-74.

PMID: 29793075 PMC: 7112094. DOI: 10.1016/j.virol.2018.05.005.


References
1.
Niculescu 3rd A, Chen X, Smeets M, Hengst L, Prives C, Reed S . Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol Cell Biol. 1998; 18(1):629-43. PMC: 121530. DOI: 10.1128/MCB.18.1.629. View

2.
Dehde S, Rohaly G, Schub O, Nasheuer H, Bohn W, Chemnitz J . Two immunologically distinct human DNA polymerase alpha-primase subpopulations are involved in cellular DNA replication. Mol Cell Biol. 2001; 21(7):2581-93. PMC: 86889. DOI: 10.1128/MCB.21.7.2581-2593.2001. View

3.
Zhao X, Madden-Fuentes R, Lou B, Pipas J, Gerhardt J, Rigell C . Ataxia telangiectasia-mutated damage-signaling kinase- and proteasome-dependent destruction of Mre11-Rad50-Nbs1 subunits in Simian virus 40-infected primate cells. J Virol. 2008; 82(11):5316-28. PMC: 2395194. DOI: 10.1128/JVI.02677-07. View

4.
Bullock P, Tevosian S, Jones C, Denis D . Mapping initiation sites for simian virus 40 DNA synthesis events in vitro. Mol Cell Biol. 1994; 14(8):5043-55. PMC: 359023. DOI: 10.1128/mcb.14.8.5043-5055.1994. View

5.
Grana X, Reddy E . Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene. 1995; 11(2):211-9. View